Technology for the world of tomorrow
Exhaled breath condensate is collected at the point-of-care through standard non-invasive procedures.
Our chemiluminescent assay reacts with asthmatic biomarkers, chemicals exhaled from the lungs during airway inflammation.
The BioSense device measures reaction kinetics to determine the severity of a patient's airway inflammation in just 30 seconds. A mobile application that uses a HIPPA compliant Bluetooth 5.0 connection to interface with the device and securely store patient data, allows users to track lung function, analyze the efficacy of medication, and identify possible environmental triggers.